A detailed history of Cibc Asset Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 45,184 shares of BIIB stock, worth $7.13 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
45,184
Previous 42,675 5.88%
Holding current value
$7.13 Million
Previous $9.89 Million 11.46%
% of portfolio
0.03%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$189.07 - $236.8 $474,376 - $594,131
2,509 Added 5.88%
45,184 $8.76 Million
Q2 2024

Aug 01, 2024

SELL
$190.52 - $236.72 $39,056 - $48,527
-205 Reduced 0.48%
42,675 $9.89 Million
Q1 2024

May 09, 2024

BUY
$212.02 - $267.71 $507,575 - $640,897
2,394 Added 5.91%
42,880 $9.25 Million
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $7,790 - $9,377
35 Added 0.09%
40,486 $10.5 Million
Q3 2023

Oct 30, 2023

BUY
$253.3 - $285.89 $993,949 - $1.12 Million
3,924 Added 10.74%
40,451 $10.4 Million
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $54,499 - $62,975
-198 Reduced 0.54%
36,527 $10.4 Million
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $40,023 - $45,605
156 Added 0.43%
36,725 $10.2 Million
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $14,136 - $17,176
56 Added 0.15%
36,569 $10.1 Million
Q3 2022

Nov 03, 2022

BUY
$194.69 - $268.46 $340,902 - $470,073
1,751 Added 5.04%
36,513 $9.75 Million
Q2 2022

Aug 09, 2022

BUY
$187.54 - $223.02 $727,842 - $865,540
3,881 Added 12.57%
34,762 $7.09 Million
Q1 2022

May 06, 2022

BUY
$193.77 - $244.14 $169,742 - $213,866
876 Added 2.92%
30,881 $6.5 Million
Q4 2021

Feb 08, 2022

BUY
$223.92 - $287.77 $476,725 - $612,662
2,129 Added 7.64%
30,005 $7.2 Million
Q3 2021

Nov 09, 2021

BUY
$282.99 - $369.05 $77,822 - $101,488
275 Added 1.0%
27,876 $7.89 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $162,134 - $259,608
626 Added 2.32%
27,601 $9.56 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $1.27 Million - $1.49 Million
-5,221 Reduced 16.22%
26,975 $7.55 Million
Q4 2020

Feb 03, 2021

BUY
$236.26 - $355.63 $393,372 - $592,123
1,665 Added 5.45%
32,196 $7.88 Million
Q3 2020

Nov 05, 2020

BUY
$264.77 - $305.71 $1.4 Million - $1.62 Million
5,298 Added 21.0%
30,531 $8.66 Million
Q2 2020

Jul 28, 2020

SELL
$258.66 - $342.55 $330,308 - $437,436
-1,277 Reduced 4.82%
25,233 $6.75 Million
Q1 2020

Apr 30, 2020

BUY
$268.85 - $341.04 $127,703 - $161,994
475 Added 1.82%
26,510 $8.39 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $246,027 - $339,950
-1,118 Reduced 4.12%
26,035 $7.73 Million
Q3 2019

Oct 30, 2019

SELL
$217.44 - $243.88 $68,276 - $76,578
-314 Reduced 1.14%
27,153 $6.32 Million
Q2 2019

Aug 05, 2019

SELL
$219.29 - $241.72 $12,938 - $14,261
-59 Reduced 0.21%
27,467 $6.42 Million
Q1 2019

May 06, 2019

SELL
$216.71 - $338.96 $118,323 - $185,072
-546 Reduced 1.94%
27,526 $6.51 Million
Q4 2018

Feb 12, 2019

BUY
$278.5 - $352.75 $121,704 - $154,151
437 Added 1.58%
28,072 $8.45 Million
Q3 2018

Nov 02, 2018

SELL
$293.51 - $383.83 $147,929 - $193,450
-504 Reduced 1.79%
27,635 $9.76 Million
Q2 2018

Aug 09, 2018

BUY
$257.52 - $306.91 $318,037 - $379,033
1,235 Added 4.59%
28,139 $8.17 Million
Q1 2018

Apr 30, 2018

SELL
$260.13 - $367.91 $114,977 - $162,616
-442 Reduced 1.62%
26,904 $7.37 Million
Q4 2017

Feb 02, 2018

SELL
$307.64 - $344.58 $282,105 - $315,979
-917 Reduced 3.24%
27,346 $8.71 Million
Q3 2017

Nov 06, 2017

BUY
$281.15 - $329.69 $7.95 Million - $9.32 Million
28,263
28,263 $8.85 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.